Production (Stage)
Kyverna Therapeutics, Inc.
KYTX
$3.39
$0.4515.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 242.65M | 285.98M | 321.59M | 346.24M | 369.79M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.00M | 4.62M | 3.79M | 2.59M | 5.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 247.65M | 290.60M | 325.37M | 348.82M | 375.49M |
|
|
|||||
| Total Current Assets | 247.65M | 290.60M | 325.37M | 348.82M | 375.49M |
| Net Property, Plant & Equipment | 8.80M | 10.66M | 11.38M | 12.51M | 12.75M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.20M | 3.39M | 2.44M | 1.79M | 1.74M |
| Total Assets | 260.66M | 304.65M | 339.20M | 363.12M | 389.98M |
|
|
|||||
| Total Accounts Payable | 8.47M | 4.62M | 9.93M | 4.86M | 7.45M |
| Total Accrued Expenses | 21.24M | 11.13M | 17.12M | 14.75M | 10.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.59M | 3.94M | 3.93M | 3.87M | 3.72M |
| Total Finance Division Other Current Liabilities | -- | 14.06M | -- | -- | -- |
| Total Other Current Liabilities | -- | 14.06M | -- | -- | -- |
| Total Current Liabilities | 33.29M | 33.76M | 30.99M | 23.48M | 21.87M |
|
|
|||||
| Total Current Liabilities | 33.29M | 33.76M | 30.99M | 23.48M | 21.87M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.35M | 4.30M | 5.21M | 6.13M | 7.13M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 296.00K | -- | -- |
| Total Liabilities | 36.65M | 38.06M | 36.49M | 29.61M | 28.99M |
|
|
|||||
| Common Stock & APIC | 532.17M | 530.00M | 528.59M | 525.09M | 523.73M |
| Retained Earnings | -308.16M | -263.52M | -226.03M | -191.54M | -162.74M |
| Treasury Stock & Other | -1.00K | 105.00K | 153.00K | -37.00K | -1.00K |
| Total Common Equity | 224.01M | 266.59M | 302.71M | 333.51M | 360.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 224.01M | 266.59M | 302.71M | 333.51M | 360.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 224.01M | 266.59M | 302.71M | 333.51M | 360.99M |
|
|
|||||